Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Mingliang Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8491-8115; OpenAlex author ID A5100616088. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 3 papers · 2019: 3 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers

Papers 9

  1. Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2023.11.028↗
  2. Improved Antitumor Efficiency of N4 -Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemotherapy. Co-author DOI 10.2147/ijn.s485861↗
  3. Nutrient Stress-Dysregulated Antisense lncRNA GLS-AS Impairs GLS-Mediated Metabolism and Represses Pancreatic Cancer Progression. Co-author DOI 10.1158/0008-5472.can-18-0419↗
  4. Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein. Co-author DOI 10.7150/thno.30988↗
  5. LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α. Co-author DOI 10.7150/thno.34559↗
  6. MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer. Co-author DOI 10.1038/s41388-017-0082-2↗
  7. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Co-author DOI 10.1038/s41388-018-0382-1↗
  8. The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose. Co-author DOI 10.1038/s41419-017-0158-5↗
  9. MiR-548an, Transcriptionally Downregulated by HIF1α/HDAC1, Suppresses Tumorigenesis of Pancreatic Cancer by Targeting Vimentin Expression. Co-author DOI 10.1158/1535-7163.mct-15-0877↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shi-Jiang Deng · 7 shared papers, 2016–2019 · strength 0.51
  2. Gang Zhao · 7 shared papers, 2016–2019 · strength 0.51
  3. Zhu Zeng · 6 shared papers, 2016–2019 · strength 0.44
  4. Chunyou Wang · 6 shared papers, 2016–2019 · strength 0.42
  5. Guimin Xia · 2 shared papers, 2024 · strength 0.41
  6. Xiaowei Wang · 2 shared papers, 2024 · strength 0.41
  7. Ye Zeng · 5 shared papers, 2018–2019 · strength 0.39
  8. Shichang Deng · 5 shared papers, 2016–2019 · strength 0.34
  9. Shuai Zhu · 5 shared papers, 2016–2019 · strength 0.34
  10. Fengyu Xu · 4 shared papers, 2018–2019 · strength 0.32
  11. Yan Li · 1 shared paper, 2024 · strength 0.21
  12. Dan Wang · 1 shared paper, 2024 · strength 0.21
  13. Dan Wang · 1 shared paper, 2024 · strength 0.20
  14. Hongwei Lü · 1 shared paper, 2024 · strength 0.20
  15. Yan Jin · 3 shared papers, 2016–2018 · strength 0.19
  16. Xiang Li · 3 shared papers, 2016–2018 · strength 0.19
  17. Qiang Li · 2 shared papers, 2018–2019 · strength 0.15
  18. Qiang Li · 1 shared paper, 2019 · strength 0.09
  19. Wei Li · 1 shared paper, 2019 · strength 0.08
  20. Yuhang Hu · 1 shared paper, 2019 · strength 0.08
  21. Qi Qin · 1 shared paper, 2018 · strength 0.08
  22. Yi Niu · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.